Conflict of interest: The authors declare no conflict of interest. Dr. RMC Herings and Dr. MPP van Herk-Sukel are employees of the PHARMO Institute for Drug Outcomes Research. This independent research institute performs financially supported studies for government and related healthcare authorities and several pharmaceutical companies. This study however, is not financially supported by a pharmaceutical company.
Incident cancer risk after the start of aspirin use: Results from a Dutch population-based cohort study of low dose aspirin users
Version of Record online: 9 DEC 2013
© 2013 UICC
International Journal of Cancer
Volume 135, Issue 1, pages 157–165, 01 July 2014
How to Cite
Hollestein, L. M., van Herk-Sukel, M. P.P., Ruiter, R., de Vries, E., Mathijssen, R. H.J., Wiemer, E. A.C., Stijnen, T., Coebergh, J.-W. W., Lemmens, V. E.P.P., Herings, R. M.C., Stricker, B. H.C. and Nijsten, T. (2014), Incident cancer risk after the start of aspirin use: Results from a Dutch population-based cohort study of low dose aspirin users. Int. J. Cancer, 135: 157–165. doi: 10.1002/ijc.28634
- Issue online: 17 APR 2014
- Version of Record online: 9 DEC 2013
- Accepted manuscript online: 28 NOV 2013 02:06AM EST
- Manuscript Accepted: 4 NOV 2013
- Manuscript Revised: 31 OCT 2013
- Manuscript Received: 15 AUG 2013
- 6Eindhoven Cancer Registry. Avalable at: <http://www.ikz.nl/page.php?id=2898&nav_id=160>. (Accessed: 27 April 2013).
- 8Dutch federation of Biomedical Scientific Societies, Code of conduct for health research, 2004.
- 9PHARMO institute for drug outcome research. Available at: <http://www.pharmo.nl/>. (Accessed: 15 May 2013).
- 172012;23:1451–61., , , et al. Non-steroidal anti-inflammatory drugs, acetaminophen, and risk of skin cancer in the Nurses' health study. Cancer Causes Control